Showing results (11-20 of 81) with videos related to
Sort By:
Pageof 9
Molecular Immunology|November 6, 2007
Recognition of allo-peptide is governed by novel anchor imposition and limited variations in TCR contact residuesCorbett J A Reinbold, Subramaniam MalarkannanJournal of Leukocyte Biology|August 5, 2010
Evasion of natural killer cells by influenza virusHailong Guo, Pawan Kumar, Subramaniam MalarkannanCritical Reviews in Immunology|November 10, 2023
Novel PI(3)K-p85α/p110δ-ITK-LAT-PLC-γ2 and Fyn-ADAP-Carma1-TAK1 Pathways Define Reverse Signaling via FasLPawan Kumar, Kamalakannan Rajasekaran, Subramaniam MalarkannanMolecular Immunology|December 17, 2008
Murine NKG2D ligands: "double, double toil and trouble"Asanga Samarakoon, Haiyan Chu, Subramaniam MalarkannanCommunications Biology|June 25, 2024
Transcriptomic diversity of innate lymphoid cells in human lymph nodes compared to BM and spleenElaheh Hashemi, Colleen McCarthy, Sridhar Rao, et al.Cellular & Molecular Immunology|January 30, 2018
The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammationWenwen Xu, TạMinh Hiếu, Subramaniam Malarkannan, et al.Frontiers in Immunology|October 7, 2015
The Fyn-ADAP Axis: Cytotoxicity Versus Cytokine Production in Killer CellsZachary J Gerbec, Monica S Thakar, Subramaniam MalarkannanThe Journal of Experimental Medicine|September 24, 2008
The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generationHailong Guo, Asanga Samarakoon, Bart Vanhaesebroeck, et al.Frontiers in Oncology|February 21, 2020
Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular TherapyMonica S Thakar, Tyce J Kearl, Subramaniam MalarkannanBlood|August 26, 2004
NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptorsJeyarani Regunathan, Yuhong Chen, Demin Wang, et al.Pageof 9